Roche Holding AG Participation (ROGN)

6,347.220
+53.470(+0.85%)
  • Volume:
    30
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    6,347.220 - 6,347.220

ROGN Overview

Prev. Close
6,293.75
Day's Range
6,347.22-6,347.22
Revenue
-
Open
6,347.22
52 wk Range
6,164-8,541.36
EPS
17.85
Volume
30
Market Cap
6.53T
Dividend (Yield)
9.30
(3.01%)
Average Vol. (3m)
1,938
P/E Ratio
17.67
Beta
0.297
1-Year Change
-14.77%
Shares Outstanding
801,094,291
Next Earnings Date
-
What is your sentiment on Roche Holding Participation?
or
Market is currently closed. Voting is open during market hours.

Roche Holding AG Participation Analysis

Roche Holding AG Participation Company Profile

Roche Holding AG Participation Company Profile

Employees
100920
  • Type:Equity
  • Market:Mexico
  • ISIN:CH0012032048

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.

Read More

Analyst Price Target

Average376.070 (+14.48% Upside)
High450
Low300
Price328.5
No. of Analysts24
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • macd indicators showing a nice jump coming, keeping my fingers crossed during these dark times
    0
    • What happened today?
      0
      • The SKYSCRAPER-01 study evaluating tiragolumab plus Tecentriq did not meet its co-primary endpoint of progression-free survival
        0
      • Today only this info about Roche
        0
    • A large pharmaceutical company, by the name of R. , is pushing down the value of the Spanish company's Pharmamar share price through the funds Consonance Capital and Great Point Partners, so that the biotech company accepts its offer of more than 4500 million dollars.According to this pharma, Pharmamar's products have a great future in oncology and virology, and would be fully engaged in its search for new drugs.
      4
      • hello to Marinopoulos Pharma company .!
        0
    • Trades ex dividend!!
      0
      • Currently near to Fibo 61.8 levels, a great company to buy IMO.
        0
        • Any comments?
          0
          • Still holding, not a good stock tho..
            2
        • cant make it even during pandemic, sell
          2
          • I've invested in Roche.VX, is it the right stock?
            0
            • Which one is the real Roche stock? I found out today that a big company in Germany is buying covid tests from Roche but i don't know for sure in which stock should i invest.  The stock will go surely up but i wanna be in the right one. I've invested in this one but i am not sure if it's the real one because i heard a rumour and they said that the tests are coming from FRANCE. If someone can help me understand, thank you.
              4
              • CH:ROG
                0
              • nevertheess, i would buy below 300. its probably gonna test there. roche is not perfoming at its best at the moment. when buy now the longterm ... because dividends are pretty good here. if you hold 20 years - the dividends would have paid you back the amount you spend now
                0
              • france = Sanofi is not Roche
                0
            • Roche : Rolls Out Coronavirus Antibody Test https://www.marketscreener.com/ROCHE-HOLDING-AG-9364975/news/Roche-Rolls-Out-Coronavirus-Antibody-Test-30637349/
              0